ArticleBreast (Edinburgh, Scotland)2022

Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer.

Eoin P Kerin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.